Literature DB >> 25576191

Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Kevin M Bonney1, Joann M Taylor, Edward B Thorp, Conrad L Epting, David M Engman.   

Abstract

Infection with the protozoan parasite Trypanosoma cruzi may lead to a potentially fatal cardiomyopathy known as Chagas heart disease. This disease is characterized by infiltration of the myocardium by mononuclear cells, including CD4+ T cells, together with edema, myofibrillary destruction, and fibrosis. A multifaceted systemic immune response develops that ultimately keeps parasitemia and tissue parasitosis low. T helper 1 and other pro-inflammatory T cell responses are effective at keeping levels of T. cruzi low in tissues and blood, but they may also lead to tissue inflammation when present chronically. The mechanism by which the inflammatory response is regulated in T. cruzi-infected individuals is complex, and the specific roles that Th17 and T regulatory (Treg) cells may play in that regulation are beginning to be elucidated. In this study, we found that depletion of Treg cells in T. cruzi-infected mice leads to reduced cardiac parasitosis and inflammation, accompanied by an augmented Th1 response early in the course of infection. This is followed by a downregulation of the Th1 response and increased Th17 response late in infection. The effect of Treg cell depletion on the Th1 and Th17 cells is not observed in mice immunized with T. cruzi in adjuvant. This suggests that Treg cells specifically regulate Th1 and Th17 cell responses during T. cruzi infection and may also be important for modulating parasite clearance and inflammation in the myocardium of T. cruzi-infected individuals.

Entities:  

Mesh:

Year:  2015        PMID: 25576191      PMCID: PMC4336812          DOI: 10.1007/s00436-014-4300-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  80 in total

Review 1.  Parasitic diseases of the heart.

Authors:  Louis V Kirchhoff; Louis M Weiss; Murray Wittner; Herbert B Tanowitz
Journal:  Front Biosci       Date:  2004-01-01

2.  Th17 cells in inflammatory conditions.

Authors:  Anne Cooke
Journal:  Rev Diabet Stud       Date:  2006-08-10

3.  Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.

Authors:  L Zhang; R L Tarleton
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

Authors:  E Suri-Payer; A Z Amar; A M Thornton; E M Shevach
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

5.  Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues.

Authors:  Rodrigo P Soares; Ana C Torrecilhas; Rafael R Assis; Marcele N Rocha; Felipe A Moura e Castro; Gustavo F Freitas; Silvane M Murta; Sara L Santos; Alexandre F Marques; Igor C Almeida; Alvaro J Romanha
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

6.  Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.

Authors:  Joshua Kotner; Rick Tarleton
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

7.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

8.  Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.

Authors:  Juliana F Vasconcelos; Bruno S F Souza; Thayse F S Lins; Letícia M S Garcia; Carla M Kaneto; Geraldo P Sampaio; Adriano C de Alcântara; Cássio S Meira; Simone G Macambira; Ricardo Ribeiro-dos-Santos; Milena B P Soares
Journal:  FASEB J       Date:  2013-08-20       Impact factor: 5.191

9.  Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Authors:  Adam P Kohm; Jeffrey S McMahon; Joseph R Podojil; Wendy Smith Begolka; Mathew DeGutes; Deborah J Kasprowicz; Steven F Ziegler; Stephen D Miller
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

10.  In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure.

Authors:  Denise Bertulucci Rocha Rodrigues; Marlene Antonia dos Reis; Audrey Romano; Sanívia Aparecida de Lima Pereira; Vicente de Paula Antunes Teixeira; Sebastião Tostes; Virmondes Rodrigues
Journal:  Clin Dev Immunol       Date:  2012-07-03
View more
  13 in total

1.  Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis.

Authors:  A Arce-Sillas; D D Álvarez-Luquín; G Cárdenas; D Casanova-Hernández; G Fragoso; M Hernández; J V Proaño Narváez; F García-Vázquez; A Fleury; E Sciutto; L Adalid-Peralta
Journal:  Clin Exp Immunol       Date:  2015-11-11       Impact factor: 4.330

Review 2.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

3.  Quantification of Trypanosoma cruzi in Tissue and Trypanosoma cruzi Killing Assay.

Authors:  Hisako Kayama; Shoko Kitada; Kiyoshi Takeda
Journal:  Bio Protoc       Date:  2017-11-20

4.  Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy.

Authors:  Bruna F Pinto; Nayara I Medeiros; Andrea Teixeira-Carvalho; Jacqueline A Fiuza; Silvana M Eloi-Santos; Maria C P Nunes; Silvana A Silva; Tereza C M Fontes-Cal; Mayara Belchior-Bezerra; Walderez O Dutra; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  Front Cardiovasc Med       Date:  2022-05-19

Review 5.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

6.  Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi.

Authors:  Melisa Gorosito Serrán; Jimena Tosello Boari; Facundo Fiocca Vernengo; Cristian G Beccaría; María C Ramello; Daniela A Bermejo; Amelia G Cook; Carola G Vinuesa; Carolina L Montes; Eva V Acosta Rodriguez; Adriana Gruppi
Journal:  Front Immunol       Date:  2017-11-21       Impact factor: 7.561

7.  Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection.

Authors:  Mariana Gatto; Larissa Ragozo Cardoso Oliveira; Fernanda De Nuzzi Dias; João Pessoa Araújo Júnior; Carlos Roberto Gonçalves Lima; Eliana Peresi Lordelo; Rodrigo Mattos Dos Santos; Cilmery Suemi Kurokawa
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-12-12

8.  BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection.

Authors:  Shoko Kitada; Hisako Kayama; Daisuke Okuzaki; Ritsuko Koga; Masao Kobayashi; Yasunobu Arima; Atsushi Kumanogoh; Masaaki Murakami; Masahito Ikawa; Kiyoshi Takeda
Journal:  J Exp Med       Date:  2017-03-29       Impact factor: 14.307

Review 9.  The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease.

Authors:  Gonzalo R Acevedo; Magalí C Girard; Karina A Gómez
Journal:  Front Immunol       Date:  2018-08-24       Impact factor: 7.561

Review 10.  Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection.

Authors:  Manuel Fresno; Núria Gironès
Journal:  Front Microbiol       Date:  2018-03-01       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.